Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes – OncoDaily
Double CHEK2 Pathogenic and Low-Risk Variants and Associated Cancer Phenotypes / Brittany L. Bychkovsky, cancer, Cancer Phenotypes, Carolyn Horton, Colin
Related Articles
The User’s Guide to Amivantamab
Targeted Oncology – Targeted therapies have revolutionized treatment of non-small-cell lung cancer (NSCLC); however, epidermal growth factor receptor (EGFR) exon20ins mutations are resistant to…
Opinion | Now Will We Believe What Is Happening Right Before Our Eyes?
There can be no appeasement. None.
NIH plans to slash support for indirect research costs, sending shockwaves through science
The NIH said Friday night that it would slash support for indirect costs on all existing and future grants to 15%
NIH plans to slash support for indirect research costs, sending shockwaves through science
The NIH said Friday night that it would slash support for indirect costs on all existing and future grants to 15%
NIH plans to slash support for indirect research costs, sending shockwaves through science
The NIH said Friday night that it would slash support for indirect costs on all existing and future grants to 15%
Health Rounds: Vaccine keeps advanced kidney cancer from recurring
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still cancer-free years later in a small early-stage trial,…
Industry Payments and Sentiments Toward Robotic Surgery Among US Physicians
This cohort study uses publicly available social media posts to assess US-based physicians’ sentiments toward robotic surgery and whether industry payments are associated with those…
Belgian regulator recommends blocking Indian drugmaker’s API production
Indian drugmaker Maithili Life Sciences has received a non-compliant report from the Brussels-based Federal Agency for Medicines and Health Products for issues related to APIs.
NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates…
NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates…